S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
The gold catalyst we’ve waited for (Ad)
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
The gold catalyst we’ve waited for (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
The gold catalyst we’ve waited for (Ad)
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
The gold catalyst we’ve waited for (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
The gold catalyst we’ve waited for (Ad)
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
The gold catalyst we’ve waited for (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Urgent Warning (Ad)
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
The gold catalyst we’ve waited for (Ad)
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
The gold catalyst we’ve waited for (Ad)
Adele extends Las Vegas residency, plans concert film
Berlin climate proposal fails to get enough yes votes to win
TSE:PRN

Profound Medical - PRN Stock Forecast, Price & News

C$12.64
+0.45 (+3.69%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
C$12.01
C$12.64
50-Day Range
C$12.19
C$18.00
52-Week Range
C$4.21
C$18.33
Volume
3,200 shs
Average Volume
22,125 shs
Market Capitalization
C$264.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PRN stock logo

About Profound Medical (TSE:PRN) Stock

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Receive PRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

PRN Stock News Headlines

The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Profound Medical Clarifies Recent Insider Buying
See More Headlines
Receive PRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

PRN Company Calendar

Today
3/26/2023
Next Earnings (Estimated)
5/08/2023

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
146
Year Founded
N/A

Profitability

Net Income
C$-28,670,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$6.68 million
Cash Flow
C$3.89 per share
Book Value
C$2.49 per share

Miscellaneous

Free Float
N/A
Market Cap
C$264.30 million
Optionable
Optionable
Beta
1.23

Key Executives

  • Dr. Arun Swarup Menawat MBA (Age 68)
    Ph.D., Chairman & CEO
    Comp: $3.08M
  • Mr. Rashed Dewan (Age 55)
    Chief Financial Officer
    Comp: $198.13k
  • Dr. Mathieu Burtnyk (Age 41)
    Sr. VP of Product Leader TULSA-PRO
    Comp: $221.27k
  • Mr. Stephen Kilmer
    Investor Relations
  • Mr. Hartmut Warnken
    Chief Commercial Officer of OUS
  • Mr. Jacques F. Cornet (Age 67)
    Sr. VP & Product Leader Sonalleve
  • Mr. Abbey Goodman
    Chief Commercial Officer of US
  • Mr. Matthew Sobczyk C.A.
    CPA, Assistant Corp. Controller
  • Mr. Levant Tinaz
    Software Developer













PRN Stock - Frequently Asked Questions

How have PRN shares performed in 2023?

Profound Medical's stock was trading at C$14.48 at the beginning of 2023. Since then, PRN shares have decreased by 12.7% and is now trading at C$12.64.
View the best growth stocks for 2023 here
.

When is Profound Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our PRN earnings forecast
.

What other stocks do shareholders of Profound Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Profound Medical investors own include Orocobre (ORL), Ballard Power Systems (BLDP), Whitecap Resources (WCP), Alcanna (CLIQ), Just Energy Group (JE), Kezar Life Sciences (KZR), Lithium Americas (LAC), Russel Metals (RUS) and Absolute Software Co. (ABT.TO) (ABT).

What is Profound Medical's stock symbol?

Profound Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "PRN."

How do I buy shares of Profound Medical?

Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Profound Medical's stock price today?

One share of PRN stock can currently be purchased for approximately C$12.64.

How much money does Profound Medical make?

Profound Medical (TSE:PRN) has a market capitalization of C$264.30 million and generates C$6.68 million in revenue each year. The company earns C$-28,670,000.00 in net income (profit) each year or C($1.75) on an earnings per share basis.

How many employees does Profound Medical have?

The company employs 146 workers across the globe.

How can I contact Profound Medical?

The official website for the company is www.profoundmedical.com. The company can be reached via phone at 647-476-1350.

This page (TSE:PRN) was last updated on 3/26/2023 by MarketBeat.com Staff